Abstract

Objective: Ovarian clear cell carcinoma (OCCC) is the second most common among the four subtypes of epithelial ovarian carcinoma (EOC), especially in Asia, and refractory to chemotherapy is accompanied with worse prognosis after the preliminary optimal debulking operation. OCCC may evolve from endometriosis, a chronic immune-related disease, and immunotherapy seems to be a potential alternative solution for OCCC. This study investigated the whole picture of immunological functions of OCCC during disease progression.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.